• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[肝脏疾病中的单加氧酶活性(基于安替比林代谢数据的研究)]

[Monooxigenase activity in liver diseases (study based on data of antipyrine metabolism)].

作者信息

Loginov A S, Bendikov E A, Kel'nia Zh A, Petrakov A V

出版信息

Ter Arkh. 1987;59(2):84-9.

PMID:3576485
Abstract

Hydroxylase and demethylase activity of cytochrome P450-dependent liver monooxygenases was estimated in healthy persons and patients with chronic diseases of the hepatobiliary system. Metabolite urine content and 4-hydroxyantipyrine and norantipyrine clearance were measured within 24 h after oral antipyrine administration (10 mg/kg). It was shown that progressive antipyrine metabolic derangements depended on the form and stage of chronic diffuse liver lesion, which was especially marked in patients with chronic active viral hepatitis, liver cirrhosis with or without ascites and with signs of encephalopathy. More considerable inhibition of N-demethylase monooxygenase activity as compared to hydroxylase activity in patients with chronic active viral hepatitis showed different sensitivity of some cytochrome P450 forms to pathogenetic factors. It could be of diagnostic value. The authors put forward the idea of interaction between the oxygenase and immune systems in drug detoxication in liver diseases.

摘要

在健康人和患有肝胆系统慢性疾病的患者中,评估了细胞色素P450依赖性肝单加氧酶的羟化酶和脱甲基酶活性。在口服安替比林(10mg/kg)后24小时内,测量代谢产物尿含量以及4-羟基安替比林和去甲安替比林清除率。结果表明,安替比林代谢紊乱的进展取决于慢性弥漫性肝损伤的形式和阶段,这在慢性活动性病毒性肝炎、伴有或不伴有腹水以及有脑病迹象的肝硬化患者中尤为明显。与慢性活动性病毒性肝炎患者的羟化酶活性相比,N-脱甲基酶单加氧酶活性受到更显著的抑制,这表明某些细胞色素P450形式对致病因素具有不同的敏感性。这可能具有诊断价值。作者提出了在肝脏疾病药物解毒过程中加氧酶和免疫系统之间相互作用的观点。

相似文献

1
[Monooxigenase activity in liver diseases (study based on data of antipyrine metabolism)].[肝脏疾病中的单加氧酶活性(基于安替比林代谢数据的研究)]
Ter Arkh. 1987;59(2):84-9.
2
Relationship between metabolic clearance rate of antipyrine and hepatic microsomal drug-oxidizing enzyme activities in humans without liver disease.无肝脏疾病人群中安替比林代谢清除率与肝微粒体药物氧化酶活性之间的关系。
Gastroenterology. 1981 Jan;80(1):112-8.
3
Antipyrine as a probe for human oxidative drug metabolism: identification of the cytochrome P450 enzymes catalyzing 4-hydroxyantipyrine, 3-hydroxymethylantipyrine, and norantipyrine formation.安替比林作为人类氧化药物代谢的探针:催化4-羟基安替比林、3-羟甲基安替比林和去甲安替比林形成的细胞色素P450酶的鉴定。
Clin Pharmacol Ther. 1996 Jun;59(6):613-23. doi: 10.1016/S0009-9236(96)90001-6.
4
Liver size in evaluating drug metabolizing capacity in man.肝脏大小在评估人体药物代谢能力中的作用。
Int J Clin Pharmacol Biopharm. 1979 Jun;17(6):271-6.
5
Correlations between cytochrome P-450 and oxidative metabolism of benzo[a]pyrene and 7-ethoxycoumarin in human liver in vitro and antipyrine elimination in vivo.体外人肝脏中细胞色素P-450与苯并[a]芘和7-乙氧基香豆素氧化代谢及体内安替比林消除之间的相关性。
Drug Metab Dispos. 1980 Jul-Aug;8(4):218-22.
6
Differential alterations of cytochrome P450 proteins in livers from patients with severe chronic liver disease.严重慢性肝病患者肝脏中细胞色素P450蛋白的差异改变。
Hepatology. 1995 Jan;21(1):120-8.
7
Effect of acute and chronic propranolol administration on antipyrine and paracetamol clearance in patients with chronic liver disease.急性和慢性给予普萘洛尔对慢性肝病患者安替比林和对乙酰氨基酚清除率的影响。
Am J Gastroenterol. 1989 Jul;84(7):723-6.
8
Prediction of midazolam-CYP3A inhibitors interaction in the human liver from in vivo/in vitro absorption, distribution, and metabolism data.基于体内/体外吸收、分布和代谢数据预测人肝脏中咪达唑仑与细胞色素P450 3A抑制剂的相互作用。
Drug Metab Dispos. 2001 Apr;29(4 Pt 1):443-52.
9
Hepatic and intestinal cytochrome P450 3A activity in cirrhosis: effects of transjugular intrahepatic portosystemic shunts.肝硬化患者肝脏和肠道细胞色素P450 3A活性:经颈静脉肝内门体分流术的影响
Hepatology. 2001 Dec;34(6):1103-8. doi: 10.1053/jhep.2001.29306.
10
[Effect of HF on the hepatic metabolism of dimethylnitrosamine in the rat].[高频对大鼠二甲基亚硝胺肝脏代谢的影响]
Toxicol Eur Res. 1983 Nov;5(6):273-6.